Search results
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
CNBC· 1 hour agoModerna on Thursday posted a narrower-than-expected loss for the first quarter as the company's...
mRNA Vaccines: Not Just for COVID Soon?
Medscape· 7 hours agoTo date, mRNA vaccines have had their largest global presence in combating the COVID-19 pandemic. Intensive research is underway on many other potential...
Q&A: AstraZeneca's COVID-19 vaccine and blood clots—what you need to know
Medical Xpress· 19 hours agoPharmaceutical giant AstraZeneca admitted in court this week that its COVID-19 vaccine can cause a...
MRNA Vaccine Fights Deadly Brain Tumor in Small Trial
US News & World Report· 2 hours agoAn experimental cancer vaccine can quickly reprogram a person’s immune system to attack glioblastoma, the most aggressive and lethal form of brain cancer, a small, preliminary ...
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
NBC Philadelphia· 1 hour agoModerna posted a narrower-than-expected loss for the first quarter as the company's cost-cutting...
Cancer prevention gets hope, put into the spotlight in 2025 Texas Legislature | Opinion
Austin American-Statesman via Yahoo News· 49 minutes agoThe last session of the Texas Legislature produced some of the country’s worst anti-vaccine bills in...
Moderna Puts Up Big Quarterly Beat; Could Shares Notch A Breakout?
Investor's Business Daily· 1 hour agoModerna beat Wall Street's first-quarter expectations Thursday. The news could bolster Moderna...
Two US vaccines could ship in weeks if bird flu jumps from infected cows to humans
The Independent via Yahoo News· 14 hours agoA pair of vaccines are ready to ship within weeks if the bird flu — which has been found circulating...
Moderna quarterly sales beat expectations but plummet from previous year
Reuters via Yahoo News· 1 hour ago(Reuters) -Moderna on Thursday reported quarterly revenue that beat Wall Street estimates but came...
Moderna Quarterly Sales Beat Expectations but Plummet From Previous Year
US News & World Report· 1 hour agoThe Cambridge, Massachusetts-based drugmaker reaffirmed that it expects to receive approval from regulators for its respiratory syncytial virus (RSV) vaccine in time for it ...
